Segui
Alberto Del Rio
Alberto Del Rio
Innovamol Srl
Email verificata su innovamol.com - Home page
Titolo
Citata da
Citata da
Anno
Fast and accurate predictions of binding free energies using MM‐PBSA and MM‐GBSA
G Rastelli, AD Rio, G Degliesposti, M Sgobba
Journal of computational chemistry 31 (4), 797-810, 2010
7322010
PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
V Iansante, PM Choy, SW Fung, Y Liu, JG Chai, J Dyson, A Del Rio, ...
Nature communications 6 (1), 7882, 2015
2022015
Metformin, cancer and glucose metabolism
B Salani, A Del Rio, C Marini, G Sambuceti, R Cordera, D Maggi
Endocrine-related cancer 21 (6), R461-R471, 2014
1332014
Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II
B Salani, C Marini, AD Rio, S Ravera, M Massollo, AM Orengo, A Amaro, ...
Scientific reports 3 (1), 2070, 2013
1302013
Chiral liquid chromatography contribution to the determination of the absolute configuration of enantiomers
C Roussel, A Del Rio, J Pierrot-Sanders, P Piras, N Vanthuyne
Journal of Chromatography A 1037 (1-2), 311-328, 2004
1302004
Identification of a DNA methylation signature in blood cells from persons with Down Syndrome
MG Bacalini, D Gentilini, A Boattini, E Giampieri, C Pirazzini, C Giuliani, ...
Aging (Albany NY) 7 (2), 82, 2015
1222015
Binding estimation after refinement, a new automated procedure for the refinement and rescoring of docked ligands in virtual screening
G Rastelli, G Degliesposti, A Del Rio, M Sgobba
Chemical biology & drug design 73 (3), 283-286, 2009
1172009
Structure-based design of potent aromatase inhibitors by high-throughput docking
F Caporuscio, G Rastelli, C Imbriano, A Del Rio
Journal of medicinal chemistry 54 (12), 4006-4017, 2011
1132011
Comparative analysis of pharmacophore screening tools
MPA Sanders, AJM Barbosa, B Zarzycka, GAF Nicolaes, JPG Klomp, ...
Journal of chemical information and modeling 52 (6), 1607-1620, 2012
1112012
A SMYD3 small‐molecule inhibitor impairing cancer cell growth
A Peserico, A Germani, P Sanese, AJ Barbosa, V Di Virgilio, R Fittipaldi, ...
Journal of cellular physiology 230 (10), 2447-2460, 2015
1092015
Discovery of novel and selective SIRT6 inhibitors
MD Parenti, A Grozio, I Bauer, L Galeno, P Damonte, E Millo, G Sociali, ...
Journal of medicinal chemistry 57 (11), 4796-4804, 2014
1092014
Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics
G Sociali, L Galeno, MD Parenti, A Grozio, I Bauer, M Passalacqua, ...
European journal of medicinal chemistry 102, 530-539, 2015
802015
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives
F Andreoli, A Jorge Moura Barbosa, M Daniele Parenti, A Del Rio
Current pharmaceutical design 19 (4), 578-613, 2013
802013
Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model
G Sociali, M Magnone, S Ravera, P Damonte, T Vigliarolo, M Von Holtey, ...
The FASEB Journal 31 (7), 3138, 2017
732017
CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes
A Del Rio, AJM Barbosa, F Caporuscio, GF Mangiatordi
Molecular BioSystems 6 (11), 2122-2128, 2010
692010
A meta-analysis on age-associated changes in blood DNA methylation: results from an original analysis pipeline for Infinium 450k data
MG Bacalini, A Boattini, D Gentilini, E Giampieri, C Pirazzini, C Giuliani, ...
Aging (Albany NY) 7 (2), 97, 2015
642015
Rejuvenating sirtuins: the rise of a new family of cancer drug targets
S Bruzzone, M Daniele Parenti, A Grozio, A Ballestrero, I Bauer, A Del Rio, ...
Current pharmaceutical design 19 (4), 614-623, 2013
632013
Theoretical reassessment of Whelk‐O1 as an enantioselective receptor for 1‐(4‐halogeno‐phenyl)‐1‐ethylamine derivatives
A Del Rio, JM Hayes, M Stein, P Piras, C Roussel
Chirality: The Pharmacological, Biological, and Chemical Consequences of …, 2004
602004
Exploring enantioselective molecular recognition mechanisms with chemoinformatic techniques
A Del Rio
Journal of separation science 32 (10), 1566-1584, 2009
572009
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer
C Arienti, M Zanoni, S Pignatta, A Del Rio, S Carloni, M Tebaldi, G Tedaldi, ...
Oncotarget 7 (14), 18424, 2016
562016
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20